User profiles for Rotonya Carr

Rotonya Carr

Associate Professor of Medicine, University of Washington
Verified email at uphs.upenn.edu
Cited by 2922

A new perspective on NAFLD: Focusing on lipid droplets

E Scorletti, RM Carr - Journal of hepatology, 2022 - Elsevier
Lipid droplets (LDs) are complex and metabolically active organelles. They are composed
of a neutral lipid core surrounded by a monolayer of phospholipids and proteins. LD …

Nonalcoholic fatty liver disease: pathophysiology and management

RM Carr, A Oranu, V Khungar - Gastroenterology Clinics, 2016 - gastro.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is a clinical diagnosis that includes the presence
of 5% or more hepatic steatosis as determined by liver imaging or biopsy in the absence of …

Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study

…, AS Vogel, AM Catana, K Wegermann, RM Carr… - Clinical …, 2021 - Elsevier
Background & Aims Chronic liver disease (CLD) represents a major global health burden.
We undertook this study to identify the factors associated with adverse outcomes in patients …

FXR agonists as therapeutic agents for non-alcoholic fatty liver disease

RM Carr, AE Reid - Current atherosclerosis reports, 2015 - Springer
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome and a risk factor for both cardiovascular and hepatic related morbidity and mortality. …

Pathophysiology of lipid droplet proteins in liver diseases

RM Carr, RS Ahima - Experimental cell research, 2016 - Elsevier
Cytosolic lipid droplets (LDs) are present in most cell types, and consist of a core comprising
neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of …

A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological …

…, CV Schneider, J Park, KM Lee, M Serper, RM Carr… - Nature …, 2022 - nature.com
Nonalcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease. Using
a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels …

[HTML][HTML] Alcohol effects on hepatic lipid metabolism

S Jeon, R Carr - Journal of lipid research, 2020 - ASBMB
Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease with
significant morbidity and mortality worldwide. ALD begins with simple hepatic steatosis and …

[HTML][HTML] Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice

RM Carr, G Peralta, X Yin, RS Ahima - PloS one, 2014 - journals.plos.org
Background Perilipin 2 (Plin2) is a lipid droplet protein that has roles in both lipid and glucose
homeostasis. An increase in Plin2 in liver is associated with the development of steatosis, …

Academic careers and the COVID-19 pandemic: reversing the tide

RM Carr, MB Lane-Fall, E South, D Brady… - Science Translational …, 2021 - science.org
The COVID-19 pandemic halted research operations at academic medical centers. This
shutdown has adversely affected research infrastructure, the current research workforce, and the …

Outcome of COVID‐19 in patients with autoimmune hepatitis: an international multicenter study

…, R Snijders, M Kıyıcı, M Akyıldız, N Ekin, RM Carr… - …, 2021 - Wiley Online Library
Background and Aims Data regarding outcome of COVID‐19 in patients with autoimmune
hepatitis (AIH) are lacking. Approach and Results We performed a retrospective study on …